Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3106 Ljp-1586
Potent, selective, and orally active inhibitor of semicarbazide-sensitive amine oxidase (SSAO) activity, inhibiting vascular adhesion protein 1 (VAP-1) activity and decreasing the density of macrophages in inflamed atherosclerotic plaques in mice
More description
DCC3105 Lith-o-asp
Novel pan-inhibitor of sialyltransferase (ST)
More description
DCC3104 lisa-4
The first fluorogenic dipeptide probe for
More description
DCC3103 Lipocrine
The first inhibitor of the catalytic activity of AChE and AChE-induced amyloid-beta aggregation protecting against reactive oxygen species
More description
DCC3102 Lipid Ii Binder 5107930
Lipid II binder, causing specific upregulation of the vancomycin-resistance associated gene vraX which is implicated in the cell wall stress stimulon that confers glycopeptide resistance
More description
DCC3101 Lintopride
5HT-4 antagonist with moderate 5HT-3 antagonist properties
More description
DCC3100 Linker-payload 49
Novel Fused Benzodiazepine Hybrid Payload for Antibody-Drug Conjugate (ADC)
More description
DCC3099 Linifolin A
Natural capsid inhibitor
More description
DCC3098 Lin28-let-7 Inhibitor-1
Novel inhibitor of the oncogenic Lin28-let-7 interaction
More description
DCC3097 Liguzinediol
Potent positive inotropic agent, inhibiting myocardial cell apoptosis
More description
DCC3096 Lifibrate
Inhibitor of cholinephosphotransferase (CPT), phosphatidyl-N-methylethanolamine N-methyltransferase (PME-NMT), and phosphatidyl-N,N-dimethylethanolamine N-methyltransferase (PDE-NMT)
More description
DCC3095 liarozole Hydrochloride
Novel inhibitor of AMA1–RON2 interaction, blocking merozoite invasion from schizont-infected RBCs; Cytochrome P450 inhibitor
More description
DCC3094 liafensine
Serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI); Anti-depressant
More description
DCC3093 L-histidinol Dihydrochloride
Natural precursor of histamine; reversible inhibitor of protein synthesis
More description
DCC3092 Lh-708
Novel inhibitor of cystine stone formation for treatment of cystinuria
More description
DCC3091 Lh65.3
Novel S. typhimurium infection inhibitor on the activity of DUSP3, DUSP11, and DUSP27
More description
DCC3090 Lgh447 Hydrochloride
Potent and specific pan-PIM inhibitor, inhibiting proliferation of several AML cell lines, showing dual antitumoral and bone antiresorptive effects
More description
DCC3089 Lgh00031
Novel irreversible inhibitor of cell division cycle 25B, inhibiting human cancer cells via ROS generation
More description
DCC3088 lg190178
Novel non-secosteroidal vitamin D receptor (VDR) ligand
More description
DCC3087 Lfs-829
Novel potent and selective antagonist of exportin-1, attenuating dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice
More description
DCC3086 Lfcinb6
Hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin
More description
DCC3085 levormeloxifene Fumarate
Selective estrogen receptor modulator (SERM)
More description
DCC3084 Ginsenoside Rg
Neuroprotective, anti-inflammatory, and anti-diabetic agent, protecting against DNA damage and apoptosis induced by ultraviolet light
More description
DCC3083 Levofloxacin Lactate
Respiratory quinolone antibiotic, exhibiting enhanced activity against the important respiratory pathogen Streptococcus pneumoniae
More description
DCC3082 Levocarnitine Propionate Hydrochloride
Natural carnitine derivative, playing a role in mitochondrial metabolism and demonstrating beneficial cardiovascular effects
More description
DCC3081 Levcromakalim Phosphate
Watersoluble prodrug of Levcromakalim, being more chemically robust and efficacious at lowering IOP with once daily dosing in a normotensive mouse model.
More description
DCC3080 Levallorphan Tartrate Salt
Partial agonist (antagonist) at mu and delta opioid receptors.
More description
DCC3079 leucinethiol
Inhibitor of ERAAP function
More description
DCC3078 Leucettamine A
Leukotriene B4 receptor antagonist
More description
DCC3077 Leq-506
Orally bioavailable Smoothened (Smo) antagonist
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X